Outpatient treatment with lisocabtagene maraleucel (liso-cel) in three ongoing clinical studies in relapsed/refractory (R/R) B cell non-Hodgkin lymphoma (NHL), including second-line transplant ineligible patients: TRANSCEND NHL 001, OUTREACH, and PILOT Meeting Abstract
| Authors: | Bachier, C. R.; Palomba, M. L.; Abramson, J. S.; Andreadis, C.; Sehgal, A. R.; Godwin, J.; Hildebrandt, G. C.; Siddiqi, T.; Stevens, D.; Farazi, T.; Kostic, A.; Trede, N. S.; Wang, L.; Lymp, J.; Thelen, T.; Ogasawara, K.; Maloney, D. G. |
| Abstract Title: | Outpatient treatment with lisocabtagene maraleucel (liso-cel) in three ongoing clinical studies in relapsed/refractory (R/R) B cell non-Hodgkin lymphoma (NHL), including second-line transplant ineligible patients: TRANSCEND NHL 001, OUTREACH, and PILOT |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160406249 |
| DOI: | 10.1182/blood-2019-127566 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2868 -- Source: Wos |
